492 related articles for article (PubMed ID: 16510874)
1. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes.
Sierra J; Yoshida T; Joazeiro CA; Jones KA
Genes Dev; 2006 Mar; 20(5):586-600. PubMed ID: 16510874
[TBL] [Abstract][Full Text] [Related]
2. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF.
Hamada F; Bienz M
Dev Cell; 2004 Nov; 7(5):677-85. PubMed ID: 15525529
[TBL] [Abstract][Full Text] [Related]
3. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
Tutter AV; Fryer CJ; Jones KA
Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
[TBL] [Abstract][Full Text] [Related]
4. α-Catenin interacts with APC to regulate β-catenin proteolysis and transcriptional repression of Wnt target genes.
Choi SH; Estarás C; Moresco JJ; Yates JR; Jones KA
Genes Dev; 2013 Nov; 27(22):2473-88. PubMed ID: 24240237
[TBL] [Abstract][Full Text] [Related]
5. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
6. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
8. A yeast model system for functional analysis of beta-catenin signaling.
Lee MS; D'Amour KA; Papkoff J
J Cell Biol; 2002 Sep; 158(6):1067-78. PubMed ID: 12235124
[TBL] [Abstract][Full Text] [Related]
9. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
10. The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15.
Huang X; Langelotz C; Hetfeld-Pechoc BK; Schwenk W; Dubiel W
J Mol Biol; 2009 Aug; 391(4):691-702. PubMed ID: 19576224
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
[TBL] [Abstract][Full Text] [Related]
13. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
Henderson BR; Galea M; Schuechner S; Leung L
J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
Daniels DL; Weis WI
Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression.
Kolligs FT; Hu G; Dang CV; Fearon ER
Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758
[TBL] [Abstract][Full Text] [Related]
16. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
[TBL] [Abstract][Full Text] [Related]
18. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.
Major MB; Camp ND; Berndt JD; Yi X; Goldenberg SJ; Hubbert C; Biechele TL; Gingras AC; Zheng N; Maccoss MJ; Angers S; Moon RT
Science; 2007 May; 316(5827):1043-6. PubMed ID: 17510365
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling.
Hsieh A; Kim HS; Lim SO; Yu DY; Jung G
Cancer Lett; 2011 Jan; 300(2):162-72. PubMed ID: 20971552
[TBL] [Abstract][Full Text] [Related]
20. Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells.
Li Q; Dashwood RH
J Biol Chem; 2004 Oct; 279(44):45669-75. PubMed ID: 15331612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]